← Insider buys
MNKD

MannKind Corporation · Healthcare

CEO Michael Castagna sold $253K of MannKind Corporation

Sold$252,696
$6.00Price
42,116Shares
−2%Stake

What MNKD did after the filing

Filed Dec 16Copier in Dec 17
The stock from Wed, Dec 17 open, $5.88
+2.2%
S&P 500, same days
+3.1%

Measured over 30 trading days, to the Feb 2 close.

Traded Fri, Dec 12. Filed Tue, Dec 16, 8:15 PM ET, after the close. Returns use the Dec 17 open and the Feb 2 close. Not investment advice.